447 related articles for article (PubMed ID: 12422331)
1. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
Park ES; Park CI; Kim DY; Kim YR
Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
[TBL] [Abstract][Full Text] [Related]
2. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
3. Local botulinum toxin type A injections in the treatment of spastic toes.
Suputtitada A
Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
[TBL] [Abstract][Full Text] [Related]
4. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy.
Frascarelli F; Di Rosa G; Bisozzi E; Castelli E; Santilli V
Eur J Paediatr Neurol; 2011 Jan; 15(1):59-64. PubMed ID: 20493744
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
6. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Park ES; Park CI; Chang HC; Park CW; Lee DS
Clin Rehabil; 2006 Aug; 20(8):668-74. PubMed ID: 16944824
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin injection of the subscapularis muscle.
Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
9. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
11. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
12. Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity.
Veverka T; Hluštík P; Otruba P; Hok P; Opavský R; Zapletalová J; Kaňovský P
Medicine (Baltimore); 2021 Jun; 100(25):e26356. PubMed ID: 34160405
[TBL] [Abstract][Full Text] [Related]
13. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.
Ploumis A; Varvarousis D; Konitsiotis S; Beris A
Disabil Rehabil; 2014; 36(4):313-8. PubMed ID: 23672209
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.
Ferrari A; Maoret AR; Muzzini S; Alboresi S; Lombardi F; Sgandurra G; Paolicelli PB; Sicola E; Cioni G
Res Dev Disabil; 2014 Oct; 35(10):2505-13. PubMed ID: 24995688
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
Choi JY; Jung S; Rha DW; Park ES
Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
[TBL] [Abstract][Full Text] [Related]
18. Somatosensory evoked potentials of hand muscles in stroke and their modification by botulinum toxin: a preliminary study.
Basaran A; Emre U; Karadavut KI; Bulmus N
J Rehabil Med; 2012 Jun; 44(7):541-6. PubMed ID: 22674234
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
[TBL] [Abstract][Full Text] [Related]
20. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
